cangrelor: Clinical Trials

8 trials of cangrelor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 recruiting. 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 28Completed 5, Unknown 2, Recruiting 1

Follow cangrelor: new trials by email Literature Review of cangrelor trials Research Report on cangrelor

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO
Cangrelor - Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication
Phase 2RecruitingIRCCS San Raffaele502024-04-012025-01-27
Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE)
Cangrelor - Platelet Aggregation Inhibitors
Phase 2UnknownOspedale Santa Croce-Carle Cuneo1402019-06-012019-03-05
Platelet Inhibition to Target Reperfusion Injury
Cangrelor - STEMI
Phase 2UnknownNational Heart Centre Singapore2282017-10-012022-04-26
Cangrelor to Clopidogrel or Prasugrel Transition Study
Cangrelor, Clopidogrel, Prasugrel - Coronary Artery Disease (CAD)
Phase 2CompletedThe Medicines Company152013-12-022020-02-26
Cangrelor Prasugrel Transition Study
Cangrelor, Prasugrel - Coronary Artery Disease
Phase 2CompletedThe Medicines Company122013-06-012015-06-24
Cangrelor Ticagrelor Transition Study
cangrelor, Ticagrelor - Coronary Artery Disease
Phase 2CompletedThe Medicines Company122013-01-012014-05-19
Maintenance of Platelet Inhibition With Cangrelor
cangrelor, Placebo - Acute Coronary Syndrome (ACS)
Phase 2CompletedThe Medicines Company2212008-10-012014-04-04
Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
Intravenous Glycoprotein inhibitor + ASA, Clopidogrel, Antiplatelet Therapy (ASA, Clopidogrel) - Stable Angina
Phase 2CompletedIcahn School of Medicine at Mount Sinai362007-04-012018-02-14

Conditions studied

Coronary Artery Disease (3)  ·  Acute Coronary Syndrome (2)  ·  Angina, Stable (1)  ·  Death (1)  ·  Hemorrhage (1)  ·  ST Elevation Myocardial Infarction (1)  ·  Shock, Cardiogenic (1)

Sponsors

The Medicines Company (4)  ·  IRCCS San Raffaele (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  National Heart Centre Singapore (1)  ·  Ospedale Santa Croce-Carle Cuneo (1)

Countries

United States (5)  ·  Italy (1)  ·  Singapore (1)

Top investigators

David J. Schneider, MD (2)  ·  Annapoorna S Kini, MD MRCP (1)  ·  David J. Schneider (1)  ·  Derek John Hausenloy (1)  ·  Eric Topol, MD (1)

Results publications

PMID 22253393, PMID 26381736, PMID 30421441, PMID 38742915